Compare Summit Therapeutics Inc (SMMT) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Direxion Daily TSLA Bull 2X Shares trades at $11.28. Which is the better fit depends on your goals.
| SMMT | TSLL | |
|---|---|---|
Market Cap | $10.48B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $29.32 | $23.03 |
52-Week Low | $13.05 | $10.29 |
Enterprise Value | $9.90B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
